- £68.12bn
- £80.41bn
- £30.33bn
- 87
- 46
- 95
- 91
REG - GSK PLC - GSK announces additional EAGLE-1 results
AnnouncementREG - GSK PLC - Results from long-term data relating to Shingrix
AnnouncementREG - GSK PLC - Amendment - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - FDA accepts GSK meningitis vaccine candidate file
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - Allianz Global Invs - Top 10 Holdings
AnnouncementREG - GSK PLC - Total Voting Rights
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Notice of AGM
AnnouncementREG - GSK PLC - Transfer of Treasury Shares
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - New Phase III Jemperli data in endometrial cancer
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Board Committee Change
AnnouncementREG - Allianz Global Invs - Top 10 Holdings
AnnouncementREG - GSK PLC - GSK announces positive Blenrep DREAMM-8 results
AnnouncementREG - GSK PLC - ViiV LAI vs oral SOC data in adherence-challenged
AnnouncementREG - GSK PLC - GSK Annual Report 2023 on Form 20-F
AnnouncementREG - GSK PLC - New ViiV LA formulation potential 4-month dosing
Announcement